European Healthtech startup funding raised during 2014.
In 2014, 123 European Healthtech companies raised a combined €932M across 134 funding rounds. UK led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Adaptimmune | Series A | Sep 2014 | €79M |
| Biocartis | Series D+ | Sep 2014 | €65M |
| Cell Medica | Series B | Nov 2014 | €64M |
| NovImmune | Series D+ | Feb 2014 |
| €49M |
| Ascendis Pharma | Series C | Dec 2014 | €48M |
| Wilson Therapeutics | Other | Apr 2014 | €36M |
| Quanta Fluid Solutions | Series B | Nov 2014 | €34M |
| uTest_Vamsi | Series D+ | Jan 2014 | €31M |
| Kymab | Series B | May 2014 | €29M |
| Xeltis | Series B | Dec 2014 | €27M |
| Gamida Cell | Growth/Late | Aug 2014 | €26M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Voluntis | Series D+ | Apr 2014 | €21M |
| InDex Pharmaceuticals | Other | Feb 2014 | €18M |
| AC Immune | Series D+ | Jan 2014 | €18M |
